Integrating AI with care: FDA reveals focus areas for forthcoming guidance on AI products
Posted:
The FDA is focusing on integrating #AI with care, outlining key areas for forthcoming guidance on AI products. As AI technology expands, it's crucial to ensure safe implementation.
In Bold Insight latest blog, Stephanie Wiltman breaks down the FDA's focus areas and how they'll shape the future of AI in healthcare.
A new study led by researchers from VIB and KU Leuven shows that Parkinson's disease can be divided into distinct subtypes, helping explain why a single treatment does not work for all patients. Using a machine-learning-driven analysis, the team identified…
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic…
Attendees
Sponsors and Exhibitors
Contact us